期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

尾加压素Ⅱ的非血流动力学作用及其在某些疾病中的意义 被引量：5

Nonhemodynamic effect of urotensin-Ⅱand its significance in some diseases
下载PDF
导出
摘要 Urotensin-Ⅱ is the most potent vasoconstrictor peptide ever identified.A great number of studies about hemodynamics of urotensin-Ⅱ were reported.Recently,many researches have demonstrated that urotensin-Ⅱ also has nonhemodynamic effects,such as mitogenic action,stimulating cell proliferation,promoting extracellular matrix production and so on.Nonhemodynamic effects of urotensin-Ⅱ may play a role in the pathogenesis of some diseases. Urotensin -Ⅱ is the most potent vasoconstrictor peptide ever identified. A great number of studies about hemodynamics of urotensin -Ⅱ were reported. Recently, many researches have demonstrated that urotensin -Ⅱ also has nonhemodynamic effects . such as mitogenic action, stimulating cell proliferation. promoting extracellular matrix production and so on. Nonhemodynamic effects of urotensin -Ⅱ may play a role in the pathogenesis of some diseases.
作者 陈素贤 罗萍 李才
机构地区 吉林大学再生医学科学研究所病理学研究室
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2007年第8期1654-1657,共4页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目(No.30570855)
关键词 尿紧张素类 非血流动力学 Urotensins Nonhemodynamics
分类号 R331 [医药卫生—人体生理学]
  • 相关文献

参考文献27

  • 1Ames RS,Sarau HM,Chambers JK,et al.Human urotensin Ⅱ is a potent vasocontrictor and agonist for the orphan receptor GPR14[J].Nature,1999,401 (6750):282-286.
  • 2Coulouarn Y,Lihrmann I,Jegou S,et al.Cloning of cDNA encoding the urotensin Ⅱ precursor in frog and human reveals intense expression of the urotensin Ⅱ gene in motoneurons of the spinal cord[J].Proc Natl Acad Sci USA,1998,95(26):15803-15808.
  • 3Matsushita M,Shichiri M,Imai T,et al.Co -expression of urotensin Ⅱ and its receptor(GPR14) in human cardiovascular and renal tissues[J].J Hypertens,2001,19(12):2185 -2190.
  • 4Takahashi K,Totsune K,Murakami O,et al.Expression of urotensin Ⅱ and its receptor in adrenal tumors and stimulation of proliferation of cultured tumor cells by urotensin Ⅱ[J].Peptides,2003,24(2):301-306.
  • 5张勇刚,陈亚红,马春艳,齐永芬,庞永正,杨军,张肇康,唐朝枢.尾加压素Ⅱ的促丝裂作用[J].中国动脉硬化杂志,2001,9(1):14-16. 被引量：61
  • 6Watanabe T,Pakala R,Katagiri T,et al.Synergistic effect of urotensin Ⅱ with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells[J].Circulation,2001,104(1):6-8.
  • 7Watanabe T,Pakala R,Katagiri T,et al.Synergistic effect of urotensin Ⅱ with serotonin on vascular smooth muscle cell proliferation[J].J Hypertens,2001,19(12):2191 -2196.
  • 8Ziltener P,Mueller C,Haenig B,et al.Urotensin Ⅱ mediates ERK1/2 phosphorylation and proliferation in GPR14-transfected cell lines[J].J Recept Signal Transduct Res,2002,22(1 -4):155-168.
  • 9Matsushita M,Shichiri M,Fukai N,et al.Urotensin Ⅱ is an autocrine/paracrine growth factor for the porcine renal epithelial cell line,LLCPK1[J].Endocrinology,2003,144(5):1825 -1831.
  • 10Sauzeau V,Le Mellionnec E,Bertoglio J,et al.Human urotensin Ⅱ -induced contraction and arterial smooth muscle cell proliferation are mediates by RhoA and Rho -kinase[J].Circ Res,2001,88(11):1102 -1104.

二级参考文献43

  • 1彭公永,何志义,刘启才,李冰,钟南山,冉丕鑫.尾加压素Ⅱ促兔肺动脉平滑肌细胞增殖及机理探讨[J].中国病理生理杂志,2004,20(9):1597-1600. 被引量：6
  • 2张勇刚 杨军 等.尾加压素Ⅱ在心血管系统中的作用[J].北京医科大学学报,2000,32(2):133-133.
  • 3Coulouarn Y, Jegou S, Tostivint H, et al. Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin Ⅱprecursors. FEBS-Lett, 1999, 457(1): 28～32
  • 4Ames R S, Sarau H M, Chambers J K, et al. Human urotensin Ⅱ: a potent vasoconstrictor and agonist for the orphan receptor GPR14.Nature, 1999, 401: 282～286
  • 5Liu Q, Pong S S, Zeng Z, et al. Identification of urotensin Ⅱ as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Biochem Biophys Res Commun, 1999, 266( 1 ): 174～178
  • 6Mori M, Sugo T, Abe M, et al. Urotensin Ⅱ is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14).Biochem Biophys Res Commun, 1999, 265( 1 ): 123～129
  • 7Watanabe T, Pakala R, Katagiri T, et al. Synergistic effect of urotensin ii with mildly oxidized LdL on DNA synthesis in vascular smooth muscle cells. Circulation, 2001, 104( 1 ): 16～ 18
  • 8Sauzeau V, Le Mellionnec E. Human urotensin Ⅱ-induced contraction and arterial smooth muscle ceil proliferation are mediated by RhoA and Rho-kinase. Circ Res. 2001. 88(11):l102～1104
  • 9Oldroyd S D, Morcos S K. Endothelin: what does the radiologist need to know?. Br-J-Radiol, 2000, 73(876): 1246-1251
  • 10Campbell J H, Campbell G R. Culture techniques and their applications to studies of vascular smooth muscle. Clin Sci, 1993,85:501～512

共引文献69

同被引文献43

  • 1Ames RS,Sarau HM,Chambers JK,et al.Human urotensin-Ⅱ is a potent vasoconstrictor and agonist for the orphan receptor GPR14[J].Nature,1999,401 (6750):282-286.
  • 2Montfort I,Perez-Tamayo R,Alvizouri AM,et al.Collagenase of hepatocytes and sinusoidal liver cells in the reversibility of experimental cirrhosis of the liver[J].Virehows Arch B Cell Pathol Lncl Mol Pathol,1990,59(5):281-289.
  • 3Zhao XY,Wang BE,Li XM,et al.Newly proposed fibrosis staging criterion for assessing carbon tetrachloride-and albumin complex-induced liver fibrosis in rodents[J].Pathol Int,2008,58(9):580-588.
  • 4Bosch J.Vascular deterioration in cirrhosis:the big picture[J].J Clin Gastroenterol,2007,41 (Suppl 3):S247-S253.
  • 5Heller J,Schepke M,Neef M,et al.Increased urotensin Ⅱ plasma levels in patients with cirrhosis and portal hypertension[J].J Hepatol,2002,37(6):767-772.
  • 6Kemp W,Krum H,Colman J,et al.Urotensin Ⅱ:a novel vasoactive mediator linked to chronic liver disease and portal hypertension[J].Liver Int,2007,27(9):1232-1239.
  • 7Gatta A,Bolognesi M,Merkel C.Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis[J].Mol Aspects Med,2008,29(1/2):119-129.
  • 8Kemp W,Kompa A,Phrommintikul A,et al.Urotensin Ⅱ modulates hepatic fibrosis and portal hemodynamic alterations in rats[J].Am J Physiol Gastrointest Liver Physiol,2009,297 (4):G762-G767.
  • 9Gieling RG,Burt AD,Mann DA.Fibrosis and cirrhosis reversibility molecular mechanisms[J].Clin Liver Dis,2008,12(4):915-937.
  • 10Kemp W,Roberts S,Krum H.Increased circulating urotensin Ⅱ in cirrhosis:Potential implications in liver disease[J].Peptides,2008,29(5):868-872.

引证文献5

二级引证文献14

中国病理生理杂志
2007年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部